A Turkish family with Ellis-van Creveld syndrome in six siblings; linkage analysis on 4p16 region (D4S3360-D4S2366)

D N Cağdaş1, A I Parlar, A Pac

  • 1Department of Pediatric Cardiology, Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey.

Genetic Counseling (Geneva, Switzerland)
|February 26, 2009
PubMed

Insights

This study confirms Ellis-van Creveld (EVC) Syndrome in a Turkish family using genetic linkage analysis. Molecular confirmation revealed novel cardiac and limb anomalies in affected children, expanding the known EVC phenotype.

Area of Science:

  • Genetics
  • Pediatrics
  • Medical Diagnostics

Background:

  • Ellis-van Creveld (EVC) Syndrome is a rare genetic disorder characterized by skeletal abnormalities and congenital heart defects.
  • Autosomal recessive inheritance is typical for EVC Syndrome, but specific genetic markers and phenotypic variations require further investigation.

Observation:

  • A Turkish family with six consecutively affected children presented with features consistent with EVC Syndrome.
  • Two affected siblings underwent detailed cardiologic evaluation, revealing ostium primum atrial septal defect, mitral cleft, partial abnormal pulmonary venous return, and pulmonary stenosis.

Findings:

  • Linkage analysis using polymorphic markers D4S3360-D4S2366 at the 4p16 locus confirmed the diagnosis of EVC Syndrome.
  • Complete segregation of disease and marker alleles, with affected siblings being homozygotes, supported autosomal recessive inheritance.
  • Novel cardiac anomalies (partial abnormal pulmonary venous return, pulmonary stenosis) and distinct postaxial polydactyly (bifid metacarpal and phalanges) were observed.

Implications:

  • Molecular analysis provides definitive diagnosis for EVC Syndrome, aiding in genetic counseling and family planning.
  • The identification of previously unreported cardiac and limb phenotypes expands the understanding of EVC Syndrome's clinical spectrum.
  • This study highlights the importance of comprehensive genetic and phenotypic evaluation in rare genetic disorders.